Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obturator Nerve Block for Pain After Hip Surgery
NCT03064165Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Aug 2017
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine and epinephrine in postoperative pain (2 arms), sponsored by Aarhus University. Primary endpoint: Opioid dose 0-12 hour after total hip replacement. Started Aug 2017; status: completed.
02
Drugs
bupivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03064165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03064165.